Abstract Objectives To evaluate whether the selection of first-line chemotherapy based on ERCC1 and RRM1 mRNA expression levels would improve clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients. Materials and methodsEligible patients were randomly assigned 1:1 to the experimental and control arms; the experimental arm received gemcitabine/carboplatin (GC) if ERCC1 and RRM1 expression was low, gemcitabine/vinorelbine (GV) if ERCC1 was high and RRM1 was low, docetaxel/carboplatin (DC) if ERCC1 was low and RRM1 was high, and docetaxel/vinorelbine (DV) if both were high. In the control arm, patients received DC. ResultsThis study was prematurely terminated after the futility analysis of 43 progression-free survival (PFS) events. A total of 55 patients (n = 26 in the experimental arm, n = 29 in the control arm) were evaluable for efficacy and toxicity. Nineteen (73.1 �patients were assigned to receive GC, 0 (0.0 �to GV, 4 (15.4 �to DC, and 3 (11.5 �to DV in the experimental arm. The overall response rates were 42.3 and 48.3 �n the experimental and control arms, respectively, which were not statistically different (P = 0.657). The median PFS was 5.2 months in the experimental arm and 5.4 months in the control arm (P = 0.286). The median overall survival was 17.4 months in the experimental arm and 12.6 months in the control arm (P = 0.638). The occurrence of grade 3 or higher neutropenia (69.2 vs. 93.1 �P = 0.035) and febrile neutropenia (3.8 vs. 24.1 �P = 0.054) was more common in the control arm. Conclusion ERCC1 and RRM1 mRNA expression-based chemotherapy did not improve clinical outcomes in advanced NSCLC (NCT01648517).
ERCC1               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/ERCC1                 

gemcitabine                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gemcitabine           

neutropenia                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neutropenia           

DC                            0.9952440672807676^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Direct_current        

DC                            0.9952440672807676^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Direct_current        

ERCC1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/ERCC1                 

docetaxel                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Docetaxel             

chemotherapy                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemotherapy          

gemcitabine                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gemcitabine           

PFS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progression-free_survival

control arm                   0.9999999999843112^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Control_arm           

GV                            0.9999999654792197^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Volt                  

expression                    0.9999989572982919^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gene_expression       

mRNA                          0.9998109203069085^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Messenger_RNA         

vinorelbine                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vinorelbine           

NSCLC                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-small-cell_lung_carcinoma

DV                            0.6260736905838518^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/DV                    

expression                    0.9999989572982919^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gene_expression       

control arms                  0.9999999999843112^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Control_arm           

GC                            0.9297424471602139^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gas_chromatography    

control arm                   0.9999999999843112^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Control_arm           

control arm                   0.9999999999843112^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Control_arm           

vinorelbine                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vinorelbine           

carboplatin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Carboplatin           

PFS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progression-free_survival

toxicity                      0.999999896930154^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Toxicity              

control arm                   0.9999999999843112^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Control_arm           

non-small cell lung cancer    0.999974804978351^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Non-small-cell_lung_carcinoma

DC                            0.9952440672807676^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Direct_current        

carboplatin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Carboplatin           

control arm                   0.9999999999843112^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Control_arm           

chemotherapy                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemotherapy          

GV                            0.9999999654792197^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Volt                  

ERCC1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/ERCC1                 

control arms                  0.9999999999843112^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Control_arm           

mRNA                          0.9998109203069085^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Messenger_RNA         

efficacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Efficacy              

ERCC1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/ERCC1                 

NSCLC                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-small-cell_lung_carcinoma

ERCC1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/ERCC1                 

docetaxel                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Docetaxel             

DV                            0.6260736905838518^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/DV                    

progression-free survival     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progression-free_survival

febrile neutropenia           0.9999999980852863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neutropenia           

GC                            0.9297424471602139^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gas_chromatography    

